menu search

BCTX / Why BriaCell Therapeutics Stock Is Surging Today

Why BriaCell Therapeutics Stock Is Surging Today
BriaCell Therapeutics Corp (NASDAQ: BCTX) shares are trading higher Wednesday after the company announced the U.S. Food and Drug Administration granted Fast Track status to Bria-IMT for the treatment of metastatic breast cancer. Bria-IMT is a cell-based immunotherapy. Read More
Posted: Apr 13 2022, 09:28
Author Name: Benzinga
Views: 110853

BCTX News  

BriaCell Therapeutics: Fast-Tracking High-Potential Breast Cancer Immunotherapy

By Seeking Alpha
January 30, 2023

BriaCell Therapeutics: Fast-Tracking High-Potential Breast Cancer Immunotherapy

BriaCell Therapeutics aims to create cancer immunotherapy by irradiating and engineering existing cancer cells. Lead candidate Bria-IMT for breast can more_horizontal

Why BriaCell Therapeutics Stock Is Surging Today

By Benzinga
April 13, 2022

Why BriaCell Therapeutics Stock Is Surging Today

BriaCell Therapeutics Corp (NASDAQ: BCTX) shares are trading higher Wednesday after the company announced the U.S. Food and Drug Administration grant more_horizontal


Search within

Pages Search Results: